The 2015 World Health Organization Classification of Tumors of the Pleura: Advances since the 2004 Classification.
about
Malignant mesothelioma of the pleura with desmoplastic histology: a case series and literature review.Growth suppressive effect of pegylated arginase in malignant pleural mesothelioma xenografts.Solitary Fibrous Tumors of Chest: Another Look with the Oncologic PerspectiveA massive pleural-based desmoid tumour.Correlation of neuroendocrine features with prognosis of non-small cell lung cancerGene of the month: BAP1.Malignant pleural mesothelioma and mesothelial hyperplasia: A new molecular tool for the differential diagnosis.Novel insights into mesothelioma biology and implications for therapy.Usefulness of Aquaporin 1 as a Prognostic Marker in a Prospective Cohort of Malignant Mesotheliomas.A diagnostically difficult case of a cellular pleural fluid: Morphology, immunohistochemistry, and fluorescence in situ hybridization study.Clinical staging of malignant pleural mesothelioma: current perspectives.Diagnostic value of D2-40 immunostaining for malignant mesothelioma: a meta-analysis.Improvement of Malignant Pleural Mesothelioma Prognosis: Early Diagnosis and Multimodality Treatment.Clinical Usefulness of Human Epididymis Protein 4 in Lung CancerUtility and pitfalls of immunohistochemistry in the differential diagnosis between epithelioid mesothelioma and poorly differentiated lung squamous cell carcinoma.Radical multimodality therapy for malignant pleural mesothelioma.A Nomogram to Predict Prognosis in Malignant Pleural Mesothelioma.Primary pleural squamous cell carcinoma: A diagnostic challenge.MUC4 immunohistochemistry is useful in distinguishing epithelioid mesothelioma from adenocarcinoma and squamous cell carcinoma of the lung.Occurrence of BAP1 germline mutations in cutaneous melanocytic tumors with loss of BAP1-expression: A pilot study.Rare presentation of a localised malignant pleural mesothelioma with cranial metastasis.Glypican-1 immunohistochemistry is a novel marker to differentiate epithelioid mesothelioma from lung adenocarcinoma.Immunohistochemical Expression of Aquaporin-1 in Fluoro-Edenite-Induced Malignant Mesothelioma: A Preliminary Report.The pathological and molecular diagnosis of malignant pleural mesothelioma: a literature review.Molecular markers and new diagnostic methods to differentiate malignant from benign mesothelial pleural proliferations: a literature review.Malignant pleural mesothelioma: some progress, but still a long way from cure.Biomarkers for Predicting Malignant Pleural Mesothelioma in a Mexican Population.Role of p16 deletion and BAP1 loss in the diagnosis of malignant mesothelioma
P2860
Q27311380-B0F1A84A-E46F-46DB-B347-24637650D1C2Q33630104-8BA47555-7FEB-4D7D-A8CA-BAFD75318F0FQ33745235-ECB45A20-286D-4F8A-80B6-9E95539B3529Q37515318-2BA109F1-4AB5-47E4-B78B-1DFAE0F68519Q37687692-4C8501C3-A929-4CD7-92FB-6A971C678010Q38846801-6E57F1F7-2F5B-48F5-A737-8977D41600C4Q39195364-C4A243C7-4B7C-4730-99E9-FC7C82D59C24Q39455555-44F51442-8965-40F6-A2BB-314D8A8B5B3BQ40668409-C222E368-A491-44C3-A469-ED332B5B8BAEQ41272473-1E361BB7-62C7-4F8B-83FA-2F195A4FF5D8Q41522440-301A94AB-DD49-4AD6-94E2-BFB79EFE5805Q42253792-B137210E-D22E-4A0C-A86D-2FD035ED395BQ42332509-DAA680C5-4607-4E32-8E29-273B86F7C46EQ42757388-5F8F0FAD-7C33-4556-984E-D28DEE1FD0CFQ46891964-D1521D5E-471E-46BE-AB07-3BD6A542C2D5Q47197708-C29626CF-B056-4E48-AD8F-5A3AF32D7B57Q47241187-DF906D39-DB86-44D7-9F21-C7295242CB1AQ48264657-FB7FCFC8-F92A-48EB-9565-153FE22B4FB5Q48276348-13340E48-B2DA-4356-B187-9CAD12BA6672Q48353431-F33EEF0A-3CBE-4257-BDAB-C856933CE641Q48488027-0D4AFCF7-0361-4DD5-B491-F11C42008AD8Q50071611-C8760517-C909-41BD-896B-4670973EE274Q50421336-81D11E8B-51E3-44E9-BF66-88A9DFE2724EQ51736026-ABCEB759-3A96-4ABF-A662-3E86B2972671Q52672884-8BD4AC44-6053-4613-9C4C-F070BDC8BD5DQ55064382-5B68C347-0BA4-476A-BD58-AAFC34401823Q55647308-3A7780E2-4823-4F0E-9C13-8B47CCC66CADQ58771136-7B216DC9-34A4-4491-A9CD-3529176EA2F4
P2860
The 2015 World Health Organization Classification of Tumors of the Pleura: Advances since the 2004 Classification.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
The 2015 World Health Organiza ...... since the 2004 Classification.
@en
type
label
The 2015 World Health Organiza ...... since the 2004 Classification.
@en
prefLabel
The 2015 World Health Organiza ...... since the 2004 Classification.
@en
P2093
P1476
The 2015 World Health Organiza ...... since the 2004 Classification.
@en
P2093
Andrew Churg
Victor Roggli
William D Travis
World Health Organization Committee for Tumors of the Pleura
P304
P356
10.1016/J.JTHO.2015.11.005
P577
2016-02-01T00:00:00Z